Detalhe da pesquisa
1.
Biosimilar filgrastim treatment patterns and prevention of febrile neutropenia: a prospective multicentre study in France in patients with solid tumours (the ZOHé study).
BMC Cancer
; 18(1): 1127, 2018 Nov 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30445935
2.
Zarzio®, biosimilar of filgrastim, in prophylaxis of chemotherapy-induced neutropenia in routine practice: a French prospective multicentric study.
Support Care Cancer
; 24(5): 1991-1998, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26507190
3.
ZOHé: A Prospective Study of the Use of Biosimilar Filgrastim Zarzio in Clinical Practice in Patients Treated With Chemotherapy for Lymphoid Malignancies.
Clin Lymphoma Myeloma Leuk
; 17(6): 362-369.e2, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28622961